Heidelberg Pharma AG (HPHA) – Strategy, SWOT and Corporate Finance Report
- Pages: 47
- Published: November 2023
- Report Code: MLPH123319FSA
Heidelberg Pharma AG (HPHA) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Heidelberg Pharma AG (Heidelberg Pharma) is a biopharmaceutical company that develops novel therapeutics for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple myeloma, prostate cancer, hematological cancers, non-hodgkin lymphoma, blood cancers, generic diseases and solid tumors. Through its subsidiary, Heidelberg Pharma Research GmbH provides preclinical contract research services and to develop the toxin Amanitin into oncology therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform. Heidelberg Pharma is headquartered in Ladenburg, Germany.
Scope
• Detailed information on Heidelberg Pharma AG required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Heidelberg Pharma AG in the form of a SWOT analysis
• An in-depth view of the business model of Heidelberg Pharma AG including a breakdown and examination of key business segments
• News about Heidelberg Pharma AG, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Heidelberg Pharma AG and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Heidelberg Pharma AG as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Heidelberg Pharma AGs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Navigo Proteins GmbH
Biotest AG
Baxter Oncology GmbH
Epigenomics AG
4SC AG
MediGene AG
Merck KGaA
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.